MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.eplepsyres.2014.03.012

Медицинская библиотека · Epilepsy research · 2014

The effect of phenobarbitone on cognition in adult patients with new onset epilepsy: a multi-centric prospective study from India.

Satischandra P, Rao S L, Ravat S, Jayalakhsmi S, Senapathy A, Shah Urvashi, Shunmukhi M S, Dutta Aparna, Mukaddam Q, Naik M, Subbakrishna D K, Sinha S

Клиническое исследованиеСтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

OBJECTIVE

In view of the conflicting results of cognitive and behavioral consequences of PB, the present study was planned to analyze its efficacy, serial neuropsychological functions and its impact on psychosocial functioning in adults with epilepsy while on phenobarbitone (PB).

METHODOLOGY: This prospective multi-centric study carried out across 4 centers in India included 75 adult patients of ≥18 years (M:F=52:23; age: 27.3 ± 8.5 years) with epilepsy who were prescribed phenobarbitone and underwent serial standardized neuropsychological assessment (NIMHANS battery for adults) at baseline, 1 month, 3 months, 6 months and 12 months. The demographic, seizure details and outcome measures were recorded.

RESULTS

Of the 75 patients, 63 had completed clinical and neuropsychological assessment, i.e. visit 1 (baseline), visit 4 (6 months) and visit 5 (12 months). There was no deterioration rather an improvement during the follow visits in all the neuropsychological functions. The results indicate that 16 neuropsychological variables changed significantly, viz. mental speed (p<0.001), sustained attention (p<0.001), focused attention (p<0.002), planning (p<0.001), concept formation (p<0.05), set shifting (p<0.001), verbal learning (p<0.0001), verbal memory (p<0.0001), visual memory (p<0.0001) and intelligence (p<0.001). The scales measuring the outcome of psychosocial functioning significantly changed during follow up included happiness (p<0.002), Impact of Epilepsy on patient's life (p<0.02), A-B Neuropsychological Assessment (p<0.015), HADS anxiety (p<0.001) and emotional disorder (p<0.006). There was a significant reduction in seizure severity as measured by Liverpool Seizure Severity Scale (p<0.002) and seizure freedom was maintained.

CONCLUSIONS

This study demonstrated that phenobarbitone is effective, well tolerated AED and do not have cognitive impairment over one year. There was variable but distinct improvement in cognition and psychosocial functioning, and effective seizure control could be one of the factor for it.

Для цитирования: Satischandra P, Rao S L, Ravat S, Jayalakhsmi S, Senapathy A, Shah Urvashi, Shunmukhi M S, Dutta Aparna, Mukaddam Q, Naik M, Subbakrishna D K, Sinha S. The effect of phenobarbitone on cognition in adult patients with new onset epilepsy: a multi-centric prospective study from India.. Epilepsy research. 2014. DOI: 10.1016/j.eplepsyres.2014.03.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.